跳至主要内容
临床试验/EUCTR2021-005493-25-CZ
EUCTR2021-005493-25-CZ进行中(未招募)1 期

Effect of Prophylactic Fibrinogen Concentrate In Scoliosis Surgery: A randomized pilot study (EFISS trial)

Fakultní nemocnice Brno0 个研究点目标入组 32 人开始时间: 2022年2月8日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Age < 18 years of age at the time of enrolment
  • 2. Elective scoliosis surgery
  • 3. Signed the relevant informed consent form
  • 4. Sexually active participants (= 15 years old) must agree to the use of following methods of contraception for the duration of this clinical trial:
  • a) Women - proper use of a highly reliable method of contraception, i.e. combined hormonal contraception (oral, vaginal or transdermal form), gestagen hormonal contraceptives associated with ovulation inhibition (oral or injectable form) or sexual abstinence.
  • b) Men - sexual abstinence or the use of an adequate contraceptive method (i.e. condom) in case of sexual intercourse.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 32
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Diagnosed congenital or acquired coagulopathy
  • 2. Use of anticoagulants with the exception of perioperative prophylactic administration of LMWH to prevent VTE
  • 3. Known hypersensitivity to the active substance or to any of the excipients of IMP
  • 4. History of deep vein thrombosis or pulmonary embolism
  • 5. Pregnancy and lactation.

研究者

相似试验

已完成
不适用
Effect of prophylactic fibrinogen on post operative bleeding in coronary artery bypass graft surgeryHemorrhage.Hemorrhage, not elsewhere classified
IRCT201011085140N1Tehran University of Medical Sciences60
尚未招募
3 期
The administration of fibrinogen concentrate (a component of blood involved in clotting process) to be given to those women who, after delivery of babies, develop severe bleeding to establish if this drug will prevent further blood loss or reduce the volume of blood loss.Post partum haemorrhageReproductive Health and Childbirth - Childbirth and postnatal careBlood - Clotting disorders
ACTRN12614000691640Auckland City Hospital245
招募中
3 期
Effect of fibrinogen on bleeding during pelvic surgery
IRCT20200109046064N1Iran University of Medical Sciences42
进行中(未招募)
不适用
Efficacy and safety of Fibrinogen Concentrate (Human) for on-demand treatment of acute bleeding in subjects with congenital fibrinogen deficiency - NDCongenital fibrinogen deficiency ( afibrinogenemia, severe hypofibrinogenemia)MedDRA version: 9.1Level: LLTClassification code 10016075
EUCTR2007-004088-22-ITCSL BEHRING GmbH23
进行中(未招募)
不适用
Efficacy and safety of Fibrinogen Concentrate (Human) for on-demand treatment of acute bleeding in subjects with congenital fibrinogen deficiencyFibrinogen Concentrate (Human) (FCH) - efficacy and safetyCongenital fibrinogen deficiency (afibrinogenemia, severe hypofibrinogenemia)MedDRA version: 12.0Level: LLTClassification code 10016075Term: Factor I deficiency
EUCTR2007-004088-22-DECSL Behring GmbH23